Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102222464 | 10222246 | 4 | F | 2006 | 20160715 | 20140606 | 20160721 | EXP | US-PFIZER INC-2014155232 | PFIZER | 54.00 | YR | F | Y | 91.00000 | KG | 20160721 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102222464 | 10222246 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | N | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 102222464 | 10222246 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | N | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 102222464 | 10222246 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | N | 20702 | FILM-COATED TABLET | ||||||||||
| 102222464 | 10222246 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | N | 20702 | FILM-COATED TABLET | ||||||||||
| 102222464 | 10222246 | 5 | C | COZAAR | LOSARTAN POTASSIUM | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 102222464 | 10222246 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | QD | ||||||||
| 102222464 | 10222246 | 7 | C | TRIAMTERENE. | TRIAMTERENE | 1 | 37.5 G, 1X/DAY | 0 | 37.5 | G | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102222464 | 10222246 | 1 | Low density lipoprotein increased |
| 102222464 | 10222246 | 2 | Cardiovascular event prophylaxis |
| 102222464 | 10222246 | 3 | Blood cholesterol |
| 102222464 | 10222246 | 4 | Blood triglycerides increased |
| 102222464 | 10222246 | 5 | Blood pressure abnormal |
| 102222464 | 10222246 | 6 | Blood pressure abnormal |
| 102222464 | 10222246 | 7 | Fluid retention |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102222464 | 10222246 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102222464 | 10222246 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102222464 | 10222246 | 1 | 2006 | 2015 | 0 | |
| 102222464 | 10222246 | 2 | 2005 | 2013 | 0 | |
| 102222464 | 10222246 | 5 | 2005 | 0 | ||
| 102222464 | 10222246 | 6 | 2005 | 0 | ||
| 102222464 | 10222246 | 7 | 2005 | 0 |